BCDA
Price
$0.92Alerts
Change
-$0.01 (-1.08%)
Updated
Nov 11 closing price
Capitalization
12.87M
Earnings call today
Intraday BUY SELL Signals
KOD
Price
$109.34Alerts
Change
+$1.28 (+1.18%)
Updated
Nov 11 closing price
Capitalization
6.24B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

BCDA vs KOD

BCDA vs KOD Comparison Chart in %
View a ticker or compare two or three
VS
BCDA vs. KOD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Hold and KOD is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BCDA with price predictions
Nov 11, 2026

BCDA's RSI Oscillator ascends from oversold territory

The RSI Indicator for BCDA moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 27 of the 31 cases the stock moved higher. This puts the odds of a move higher at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 64 cases where BCDA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for BCDA just turned positive on November 10, 2026. Looking at past instances where BCDA's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.

Following a +9.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCDA advanced for three days, in 183 of 236 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

BCDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BCDA as a result. In 95 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

BCDA moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BCDA crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for BCDA entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. BCDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.766) is normal, around the industry mean (3.498). P/E Ratio (-1.441) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.090) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (2000.000) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for KOD with price predictions
Nov 11, 2026

KOD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for KOD turned positive on November 11, 2026. Looking at past instances where KOD's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on KOD as a result. In 57 of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where KOD advanced for three days, in 230 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The 10-day RSI Indicator for KOD moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 34 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KOD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

KOD broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. KOD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: KOD's P/B Ratio (102.150) is slightly higher than the industry average of (3.498). P/E Ratio (-23.699) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KOD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
BCDA vs KOD: Fundamental Ratings
BCDA
KOD
OUTLOOK RATING
1..100
5534
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6134
P/E GROWTH RATING
1..100
3698
SEASONALITY SCORE
1..100
5028

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (87) in the null industry is in the same range as KOD (95) in the Biotechnology industry. This means that BCDA’s stock grew similarly to KOD’s over the last 12 months.

BCDA's Profit vs Risk Rating (100) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that BCDA’s stock grew similarly to KOD’s over the last 12 months.

BCDA's SMR Rating (100) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that BCDA’s stock grew similarly to KOD’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is in the same range as BCDA (61) in the null industry. This means that KOD’s stock grew similarly to BCDA’s over the last 12 months.

BCDA's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for KOD (98) in the Biotechnology industry. This means that BCDA’s stock grew somewhat faster than KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDAKOD
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BCDA: $0.92 vs. KOD: $109.34)
Brand notoriety: BCDA and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 34% vs. KOD: 28%
Market capitalization -- BCDA: $12.87M vs. KOD: $6.24B
BCDA [@Biotechnology] is valued at $12.87M. KOD’s [@Biotechnology] market capitalization is $6.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green while KOD’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • KOD’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCDA and KOD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 6 TA indicator(s) are bullish while KOD’s TA Score has 3 bullish TA indicator(s).

  • BCDA’s TA Score: 6 bullish, 4 bearish.
  • KOD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BCDA is a better buy in the short-term than KOD.

Price Growth

BCDA (@Biotechnology) experienced а +0.94% price change this week, while KOD (@Biotechnology) price change was +10.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

BCDA is expected to report earnings on Mar 30, 2027.

KOD is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been loosely correlated with XRTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BCDA jumps, then XRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
-0.91%
XRTX - BCDA
43%
Loosely correlated
+4.72%
MDGL - BCDA
29%
Poorly correlated
+0.10%
INO - BCDA
28%
Poorly correlated
+1.72%
KOD - BCDA
28%
Poorly correlated
+1.18%
AUPH - BCDA
27%
Poorly correlated
-0.55%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with RZLT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then RZLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+1.18%
RZLT - KOD
36%
Loosely correlated
+1.24%
VCYT - KOD
34%
Loosely correlated
+4.36%
MLTX - KOD
34%
Loosely correlated
+7.56%
ENTA - KOD
32%
Poorly correlated
+3.39%
SION - KOD
31%
Poorly correlated
N/A
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRO8.500.28
+3.41%
Kronos Worldwide
ODFL170.502.48
+1.48%
Old Dominion Freight Line
JRVR3.250.04
+1.09%
James River Group Holdings Ltd
GEF72.51-0.46
-0.63%
Greif
JYD1.14-0.08
-6.56%
Jayud Global Logistics Limited